Review of the clinical effectiveness of the neuraminidase inhibitors against influenza B viruses

Grants

Funding Acknowledgements

The Melbourne WHO Collaborating Centre for Reference and Research on influenza are supported by the Australian Government Department of Health and Aging. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.